A trial of antithrombotic therapy in patients with refractory migraine and antiphospholipid antibodies: A retrospective study of 75 patients.

Source : https://read.qxmd.com/read/33402037/a-trial-of-antithrombotic-therapy-in-patients-with-refractory-migraine-and-antiphospholipid-antibodies-a-retrospective-study-of-75-patients

OBJECTIVE: It has been reported that patients with antiphospholipid antibodies (aPL) and refractory migraine may experience symptomatic improvement with antithrombotic therapy, but this phenomenon has not been well studied. This study was undertaken to detail the response to trials of antithrombotic therapy in these patients.